Inclisiran for LDL cholesterol after a heart attack in Saudi Arabia
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests if adding inclisiran to standard care can lower LDL cholesterol more than standard care alone in people who recently had a heart attack or unstable angina. It aims to help patients in Saudi Arabia reduce their risk of future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had a heart attack or unstable angina within the last 7 days.
- Your LDL cholesterol is at least 70 mg/dL if you were already on cholesterol-lowering medicine, or at least 100 mg/dL if you were not.
- Your triglyceride level is below 400 mg/dL.
- Your kidney function is better than a certain level (eGFR > 30).
- You are not pregnant, breastfeeding, or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if starting inclisiran soon after a heart attack helps lower cholesterol further in patients already on statins. The goal is to see if early treatment can reduce future heart risks.
This study looks at how to best coordinate care between your regular doctor and heart specialists if you have chronic heart disease. It tests whether a special program helps you stay on the right medications to lower cholesterol.
This trial tests if giving inclisiran early after a heart attack can lower cholesterol more effectively. It is for people who have had a recent heart attack and still have high LDL cholesterol despite taking statins.
This trial tests if adding inclisiran to your current statin can reduce dangerous, rupture-prone plaque in your heart arteries. It may help if you have a moderate blockage with thin-cap plaque and your LDL cholesterol stays high despite statins.
This study tests a cholesterol-lowering injection (inclisiran) given soon after a heart attack, urgent heart procedure, or stroke. The goal is to see if it helps lower bad cholesterol quickly and safely.
This study tests a new injectable medicine called inclisiran for people who are already on many medications and have high cholesterol. It is designed for those who cannot lower their cholesterol enough with statins, especially if they have diabetes or other heart risks.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.